The FDA Denies Approval for Remoxy Extended Release; Plus Knee OA Pain Treatment Moves into Phase 3 Trials
EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray
A Comprehensive Review of NSAID Cardiovascular Toxicity
FDA Approves Combination Therapy for OA Pain, but Not Duobrii Lotion for Plaque Psoriasis
IV Tramadol Promising for Postoperative Pain; FDA Denies IV Meloxicam Approval
Nonopioid Medication May Be as Effective as Opioids for Chronic Pain
FDA to Review Abuse Deterrent Oxycodone Capsule & More
Study Examines Why Patients Exceed Recommended Doses of Ibuprofen & NSAIDs
Dermatology Patients on Corticosteroids May Not Receive Osteoporosis Screenings; Plus FDA Approves ZTLido
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 12
- Next Page »